PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in France
NCT: NCT07748572 · RECRUITING
Brief Summary
To evaluate safety and performance of the phenox GmbH Flow Diverter p64, p64 MW, and p48MW in France, this registry will include subjects with intracranial aneurysms (anterior and posterior) who are treated with a phenox GmbH Flow Diverter. The subjects will be treated according to the standard of care in the participating sites.
Frequently Asked Questions
What is PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in France?
PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in France is a clinical trial registered under NCT07748572. Current status: RECRUITING.
What is the status of NCT07748572?
The current status of NCT07748572 (PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in France) is: RECRUITING.
When did PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in France start?
PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in France started on 2025-03-07.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.